Navigation Links
Gene Therapy May Help Restore Sight In Congenital blindness

Researchers from the University of Florida announced on Monday that they have given sight to baby chickens with a disease that otherwise would have left them blind// by using a gene therapy.

The researchers hope that the gene therapy may one day prevent a hereditary form of childhood blindness after they had achieved a promising study on chickens with the same condition. They explained that the research, which delayed the onset of blindness in chickens, might one day protect children from becoming blind due to an inherited disease called Leber congenital amaurosis (LCA).

Susan Semple-Rowland at the University of Florida in Gainesville, Florida, US, who led the study, explained that the chickens with the disease are normally born blind. And she further explained that six out of seven chickens that had undergone the gene therapy technique while still in the egg hatched out with sight.

She and her colleagues focused their study on mutations in the GUCY2D gene, which is responsible for LCA1 the most common type of LCA, accounting for up to 20% of cases of blindness. They explained that in people who carry two faulty GUCY2D genes, the cells at the back of the eye are unable to respond properly to light, and therefore cannot send proper visual signals to the brain. They also said that the individuals who suffer from this disorder typically become blind in infancy.

The scientists explained that they used a virus containing a normal copy of the defective photoreceptor gene and injected it through an eggshell into the developing chicken embryo. Rowland said that after the first treated chick had hatched, it began to peck at little dots on a piece of paper. The scientists have however noted that the procedure had slowed the degeneration of the chicks' photoreceptors, but it did not completely halt it.

‘The visual capabilities of the treated animals far exceeded our expectations’, said Rowland, about their study that is set to appear today in the online journal Public Library of Science-Medicine. She speculated that this therapy if adapted to humans might work any time till the age of 5 yrs, but she also did mention that she was not advocating in-utero treatment.

Gene therapy in general remains controversial, and the adverse effects in humans remain relatively uncertain. There is still a doubt for example that the modified virus used to restore vision in chickens may cause an adverse reaction in people.

'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2016)... Atlanta, GA (PRWEB) , ... May 31, 2016 ... ... Contact Center Solutions , today announced it has been included by Gartner, ... 2016 report mentions a wide range of Contact Center Infrastructure technologies, some of ...
(Date:5/31/2016)... ... May 31, 2016 , ... Splashtop Inc., the worldwide leader ... with e-Jan Networks Co., the leading provider of secure mobile remote access solution ... Networks’s leading CACHATTO remote access solution. Splashtop for CACHATTO will be ...
(Date:5/31/2016)... ... May 31, 2016 , ... St. Joseph Medical Center (SJMC) ... exchange, which enables physicians at SJMC’s two hospital campuses, downtown and in the ... in the exchange. SJMC’s membership in the health information exchange underscores the hospital’s ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Twenty years ago ... experience, rather than trying to silence the voices they hear. But this approach has ... itself. , The method has steadily gained credibility and now is used around the ...
(Date:5/31/2016)... ... 31, 2016 , ... The University of Tennessee Medical Center ... the latest in Clinical Patient Pod (CPP) technologies provided through Jvion’s ... into the clinical workflow. These insights are empowering the more than 30 case ...
Breaking Medicine News(10 mins):
(Date:5/31/2016)... May 31, 2016   Plexus Technology Group, ... anesthesia information management systems (AIMS), is pleased to ... as Vice President of Technology. In this new ... aspects of the company,s technological development. He will ... to determine the expansion of new products, product ...
(Date:5/31/2016)... , May 31, 2016 ... market is progressing at a CAGR of 10.6% within ... was valued at US$0.46 bn in 2013. Owing to ... expected to reach US$0.88 bn by the end of ... derived from the market,s holistic representation in a research ...
(Date:5/31/2016)... , May 31, 2016 ... the initiation of a first-in-human clinical trial of its ... molecule - S101 is currently being developed for the ... study is designed to evaluate the safety and tolerability ... at several sites across the United States ...
Breaking Medicine Technology: